This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
Search results
From Proteopedia
You searched for Belli,_B.A.
There is no page with the exact title "Belli,_B.A.". The search results for "Belli,_B.A." are displayed below. You can create a page titled Belli,_B.A. (by clicking on the red link).
For more information about searching Proteopedia, see Help.
To exclude pages titled with 4-character PDB codes, use the checkbox "only Human created pages" at the bottom of this page.
Showing below up to 20 results starting with #1.
View (previous 20) (next 20) (20 | 50 | 100 | 250 | 500)
Article title matches
- User:Olivier Belli (219 bytes)
1: * Full Real Name: Olivier Belli
5: * Institution (NO ABBREVIATIONS): European School of Biotechnology
7: * City, State/Province, Country: Strasbourg, France - Category:Belli, B A (41 bytes)
1: List of pages with the keyword Belli, B A - Category:Belli BA (39 bytes)
1: List of pages with the keyword Belli BA - Category:Belli, R (39 bytes)
1: List of pages with the keyword Belli, R - Category:Belli R (38 bytes)
1: List of pages with the keyword Belli R
Page text matches
- 1ysg (6,058 bytes)
2: ...ic Protein Bcl-xL in Complex with "SAR by NMR" Ligands==
3: ...uctureSection load='1ysg' size='340' side='right'caption='[[1ysg]]' scene=''>
4: == Structural highlights ==
5: ...tps://proteopedia.org/fgij/fg.htm?mol=1YSG FirstGlance]. <br>
6: ...ethod:]]</b></td><td class="sblockDat" id="methodDat">Solution NMR</td></tr> - 1ysi (6,057 bytes)
2: ...l-xL in complex with an acyl-sulfonamide-based ligand==
3: ...uctureSection load='1ysi' size='340' side='right'caption='[[1ysi]]' scene=''>
4: == Structural highlights ==
5: ...tps://proteopedia.org/fgij/fg.htm?mol=1YSI FirstGlance]. <br>
6: ...ethod:]]</b></td><td class="sblockDat" id="methodDat">Solution NMR</td></tr> - 1ysn (6,070 bytes)
2: ...cl-xL complexed with an acyl-sulfonamide-based ligand==
3: ...uctureSection load='1ysn' size='340' side='right'caption='[[1ysn]]' scene=''>
4: == Structural highlights ==
5: ...tps://proteopedia.org/fgij/fg.htm?mol=1YSN FirstGlance]. <br>
6: ...ethod:]]</b></td><td class="sblockDat" id="methodDat">Solution NMR</td></tr> - 1ysw (6,413 bytes)
2: ...Bcl-2 complexed with an acyl-sulfonamide-based ligand==
3: ...uctureSection load='1ysw' size='340' side='right'caption='[[1ysw]]' scene=''>
4: == Structural highlights ==
5: ...tps://proteopedia.org/fgij/fg.htm?mol=1YSW FirstGlance]. <br>
6: ...ethod:]]</b></td><td class="sblockDat" id="methodDat">Solution NMR</td></tr> - 1ysx (6,366 bytes)
2: ... an anti-apoptotic ligand directed against Bcl-xL and Bcl-2==
3: ...uctureSection load='1ysx' size='340' side='right'caption='[[1ysx]]' scene=''>
4: == Structural highlights ==
5: ...tps://proteopedia.org/fgij/fg.htm?mol=1YSX FirstGlance]. <br>
6: ...ethod:]]</b></td><td class="sblockDat" id="methodDat">Solution NMR</td></tr> - 2o1y (5,156 bytes)
2: ...l-xL in complex with an acyl-sulfonamide-based ligand==
3: ...uctureSection load='2o1y' size='340' side='right'caption='[[2o1y]]' scene=''>
4: == Structural highlights ==
5: ...tps://proteopedia.org/fgij/fg.htm?mol=2O1Y FirstGlance]. <br>
6: ...ethod:]]</b></td><td class="sblockDat" id="methodDat">Solution NMR</td></tr> - 2o21 (5,499 bytes)
2: ...cl-2 in complex with an acyl-sulfonamide-based ligand==
3: ...uctureSection load='2o21' size='340' side='right'caption='[[2o21]]' scene=''>
4: == Structural highlights ==
5: ...tps://proteopedia.org/fgij/fg.htm?mol=2O21 FirstGlance]. <br>
6: ...ethod:]]</b></td><td class="sblockDat" id="methodDat">Solution NMR</td></tr> - 2o22 (5,495 bytes)
2: ...cl-2 in complex with an acyl-sulfonamide-based ligand==
3: ...uctureSection load='2o22' size='340' side='right'caption='[[2o22]]' scene=''>
4: == Structural highlights ==
5: ...tps://proteopedia.org/fgij/fg.htm?mol=2O22 FirstGlance]. <br>
6: ...ethod:]]</b></td><td class="sblockDat" id="methodDat">Solution NMR</td></tr> - 2o2f (5,501 bytes)
2: ...cl-2 in complex with an acyl-sulfonamide-based ligand==
3: ...uctureSection load='2o2f' size='340' side='right'caption='[[2o2f]]' scene=''>
4: == Structural highlights ==
5: ...tps://proteopedia.org/fgij/fg.htm?mol=2O2F FirstGlance]. <br>
6: ...ethod:]]</b></td><td class="sblockDat" id="methodDat">Solution NMR</td></tr> - 2o2m (5,158 bytes)
2: ...l-xL in complex with an acyl-sulfonamide-based ligand==
3: ...uctureSection load='2o2m' size='340' side='right'caption='[[2o2m]]' scene=''>
4: == Structural highlights ==
5: ...tps://proteopedia.org/fgij/fg.htm?mol=2O2M FirstGlance]. <br>
6: ...ethod:]]</b></td><td class="sblockDat" id="methodDat">Solution NMR</td></tr> - 2o2n (5,163 bytes)
2: ...l-xL in complex with an acyl-sulfonamide-based ligand==
3: ...uctureSection load='2o2n' size='340' side='right'caption='[[2o2n]]' scene=''>
4: == Structural highlights ==
5: ...tps://proteopedia.org/fgij/fg.htm?mol=2O2N FirstGlance]. <br>
6: ...ethod:]]</b></td><td class="sblockDat" id="methodDat">Solution NMR</td></tr> - User:Olivier Belli (219 bytes)
1: * Full Real Name: Olivier Belli
5: * Institution (NO ABBREVIATIONS): European School of Biotechnology
7: * City, State/Province, Country: Strasbourg, France - Category:Belli, B A (41 bytes)
1: List of pages with the keyword Belli, B A - Category:Belli BA (39 bytes)
1: List of pages with the keyword Belli BA - 6yio (4,213 bytes)
2: ==CRYSTAL STRUCTURE OF FAB RG6292 IN COMPLEX WITH CD25 ECD==
3: ...caption='[[6yio]], [[Resolution|resolution]] 1.83&Aring;' scene=''>
4: == Structural highlights ==
5: ...tps://proteopedia.org/fgij/fg.htm?mol=6YIO FirstGlance]. <br>
6: ...d><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 1.83&#8491;</td><... - 7kmg (5,935 bytes)
2: ==LY-CoV555 neutralizing antibody against SARS-CoV-2==
3: ...caption='[[7kmg]], [[Resolution|resolution]] 2.16&Aring;' scene=''>
4: == Structural highlights ==
5: ...tps://proteopedia.org/fgij/fg.htm?mol=7KMG FirstGlance]. <br>
6: ...d><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 2.16&#8491;</td><... - 7kmh (6,048 bytes)
2: ==LY-CoV488 neutralizing antibody against SARS-CoV-2==
3: ...caption='[[7kmh]], [[Resolution|resolution]] 1.72&Aring;' scene=''>
4: == Structural highlights ==
5: ...tps://proteopedia.org/fgij/fg.htm?mol=7KMH FirstGlance]. <br>
6: ...d><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 1.72&#8491;</td><... - 7kmi (5,999 bytes)
2: ==LY-CoV481 neutralizing antibody against SARS-CoV-2==
3: ...caption='[[7kmi]], [[Resolution|resolution]] 1.73&Aring;' scene=''>
4: == Structural highlights ==
5: ...tps://proteopedia.org/fgij/fg.htm?mol=7KMI FirstGlance]. <br>
6: ...d><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 1.73&#8491;</td><... - 7p47 (3,631 bytes)
2: ==Structure of the E3 ligase Smc5/Nse2 in complex with Ubc9-SUMO thioester m...
3: ...caption='[[7p47]], [[Resolution|resolution]] 3.31&Aring;' scene=''>
4: == Structural highlights ==
5: ...tps://proteopedia.org/fgij/fg.htm?mol=7P47 FirstGlance]. <br>
6: ...d><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 3.314&#8491;</td>... - 7qkn (4,482 bytes)
2: ...HDF1 YTH domain in complex with the ebsulfur derivative compound 7==
3: ...caption='[[7qkn]], [[Resolution|resolution]] 2.15&Aring;' scene=''>
4: == Structural highlights ==
5: ...tps://proteopedia.org/fgij/fg.htm?mol=7QKN FirstGlance]. <br>
6: ...d><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 2.15&#8491;</td><...
View (previous 20) (next 20) (20 | 50 | 100 | 250 | 500)
You may also try
